VCM
BMY icon

Viewpoint Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Viewpoint Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
22,927
-7,645
-25% -$439K 0.67% 41
2026
Q1 		$1.85M Sell
30,572
-1,199
-4% -$69.9K 0.87% 35
2025
Q4 		$1.71M Sell
31,771
-47
-0.1% -$2.26K 0.74% 38
2025
Q3 		$1.43M Sell
31,818
-1,436
-4% -$67.1K 0.63% 42
2025
Q2 		$1.54M Sell
33,254
-483
-1% -$23.7K 0.76% 37
2025
Q1 		$2.06M Buy
33,737
+582
+2% +$33.9K 1.11% 27
2024
Q4 		$1.88M Buy
33,155
+2,579
+8% +$144K 0.98% 27
2024
Q3 		$1.56M Buy
30,576
+2,205
+8% +$103K 0.87% 28
2024
Q2 		$1.18M Buy
28,371
+25
+0.1% +$1.12K 0.72% 32
2024
Q1 		$1.54M Sell
28,346
-2,400
-8% -$122K 0.98% 29
2023
Q4 		$1.58M Sell
30,746
-846
-3% -$44.4K 1.1% 26
2023
Q3 		$1.83M Buy
31,592
+543
+2% +$33.3K 1.47% 22
2023
Q2 		$1.99M Buy
31,049
+183
+0.6% +$12.3K 1.54% 22
2023
Q1 		$2.14M Sell
30,866
-692
-2% -$48.8K 1.92% 15
2022
Q4 		$2.27M Sell
31,558
-2,533
-7% -$191K 2.2% 14
2022
Q3 		$2.57M Sell
34,091
-2,172
-6% -$158K 2.54% 9
2022
Q2 		$2.79M Buy
36,263
+188
+0.5% +$14.3K 2.62% 10
2022
Q1 		$2.63M Sell
36,075
-417
-1% -$28K 2.03% 14
2021
Q4 		$2.27M Buy
+36,492
New +$2.14M 1.65% 18

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viewpoint Capital Management's BMY Position: Q2 2026 in Review

Viewpoint Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q2 2026, selling an estimated $439K and leaving 22,927 shares worth $1.32M. The position accounts for 0.67% of the portfolio, ranked #41.

Viewpoint Capital Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.79M in Q2 2022. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Viewpoint Capital Management held 22,927 shares of Bristol-Myers Squibb worth $1.32M as of Q2 2026.
  • Viewpoint Capital Management sold 7,645 Bristol-Myers Squibb shares in Q2 2026, an estimated $439K.
  • Bristol-Myers Squibb made up 0.67% of Viewpoint Capital Management's portfolio in Q2 2026, its #41 holding.
  • Viewpoint Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Viewpoint Capital Management's Bristol-Myers Squibb position peaked at $2.79M in Q2 2022.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Viewpoint Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.